Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.45 |
| ▸ | RELA | Q04206 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 5/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | GFER | P55789 | 1/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.44 |
| ▸ | ACR | P10323 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | RARB | P10826 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL711908 | 0.99 | LMNA (0.47) | LMNANPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL20312218 | 0.98 | THRB (0.46) | LMNANPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL14275368 | 0.96 | LMNA (0.49) | LMNANPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL13476286 | 0.96 | LMNA (0.49) | LMNANPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL12172636 | 0.96 | LMNA (0.49) | LMNANPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL24599286 | 0.95 | LMNA (0.50) | LMNANPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL6517575 | 0.95 | LMNA (0.50) | LMNANPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL13997907 | 0.95 | LMNA (0.50) | LMNANPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL16379456 | 0.95 | LMNA (0.50) | LMNANPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL16379490 | 0.95 | LMNA (0.50) | LMNANPC1CYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080049319-A1 | POLYMERIZABLE MONOMER, AN OPTICAL COMPENSATION FILM AND A METHOD FOR PRODUCING THE OPTICAL COMPENSATION FILM | FUJIFILM CORPORATION (JP) | 2008-02-28 | — | — | US | disclosed |
| US-20080049319-A1 | POLYMERIZABLE MONOMER, AN OPTICAL COMPENSATION FILM AND A METHOD FOR PRODUCING THE OPTICAL COMPENSATION FILM | FUJIFILM CORPORATION (JP) | 2008-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080049319-A1 | POLYMERIZABLE MONOMER, AN OPTICAL COMPENSATION FILM AND A METHOD FOR PRODUCING THE OPTICAL COMPENSATION FILM | NR2E3, RAD51, RXFP3 | LMNA 2627/4885NPC1 3219/4885CYP1A2 1777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.